Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CEB-01 by Cebiotex for Liposarcoma: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Liposarcoma. According to GlobalData, Phase I drugs...
CEB-01 by Cebiotex for Leiomyosarcoma: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Leiomyosarcoma. According to GlobalData, Phase I drugs...
CEB-01 by Cebiotex for Pleomorphic Liposarcoma: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Pleomorphic Liposarcoma. According to GlobalData, Phase I...
CEB-01 by Cebiotex for Soft Tissue Sarcoma: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Soft Tissue Sarcoma. According to GlobalData, Phase...
CEB-01 by Cebiotex for Nerve Sheath Tumor: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Nerve Sheath Tumor. According to GlobalData, Phase...